文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

国际益生菌和益生元科学协会(ISAPP)关于共生元定义和范围的共识声明。

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics.

机构信息

Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL, USA.

Department of Food and Nutritional Sciences, The University of Reading, Reading, UK.

出版信息

Nat Rev Gastroenterol Hepatol. 2020 Nov;17(11):687-701. doi: 10.1038/s41575-020-0344-2. Epub 2020 Aug 21.


DOI:10.1038/s41575-020-0344-2
PMID:32826966
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7581511/
Abstract

In May 2019, the International Scientific Association for Probiotics and Prebiotics (ISAPP) convened a panel of nutritionists, physiologists and microbiologists to review the definition and scope of synbiotics. The panel updated the definition of a synbiotic to "a mixture comprising live microorganisms and substrate(s) selectively utilized by host microorganisms that confers a health benefit on the host". The panel concluded that defining synbiotics as simply a mixture of probiotics and prebiotics could suppress the innovation of synbiotics that are designed to function cooperatively. Requiring that each component must meet the evidence and dose requirements for probiotics and prebiotics individually could also present an obstacle. Rather, the panel clarified that a complementary synbiotic, which has not been designed so that its component parts function cooperatively, must be composed of a probiotic plus a prebiotic, whereas a synergistic synbiotic does not need to be so. A synergistic synbiotic is a synbiotic for which the substrate is designed to be selectively utilized by the co-administered microorganisms. This Consensus Statement further explores the levels of evidence (existing and required), safety, effects upon targets and implications for stakeholders of the synbiotic concept.

摘要

2019 年 5 月,国际益生菌和益生元科学协会(ISAPP)召集了一批营养师、生理学家和微生物学家组成的专家组,对共生元的定义和范围进行了审查。专家组更新了共生元的定义为“一种由活微生物和宿主微生物选择性利用的基质组成的混合物,对宿主具有健康益处”。专家组得出的结论是,将共生元简单地定义为益生菌和益生元的混合物可能会抑制旨在协同作用的共生元的创新。要求每个成分都必须满足益生菌和益生元各自的证据和剂量要求,这也可能是一个障碍。相反,专家组澄清说,一种互补的共生元,其组成部分没有被设计成协同作用,必须由益生菌加益生元组成,而协同的共生元则不需要。协同共生元是指其基质被设计为被共同给予的微生物选择性利用的共生元。本共识声明进一步探讨了共生元概念的证据水平(现有和所需)、安全性、对目标的影响以及对利益相关者的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf6/7581511/6dae6e5642d2/41575_2020_344_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf6/7581511/cc659061661f/41575_2020_344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf6/7581511/6dae6e5642d2/41575_2020_344_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf6/7581511/cc659061661f/41575_2020_344_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf6/7581511/6dae6e5642d2/41575_2020_344_Fig2_HTML.jpg

相似文献

[1]
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics.

Nat Rev Gastroenterol Hepatol. 2020-11

[2]
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.

Nat Rev Gastroenterol Hepatol. 2017-6-14

[3]
Probiotics/prebiotics/synbiotics and human neuropsychiatric outcomes: an umbrella review.

Benef Microbes. 2024-9-5

[4]
The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.

Diabetologia. 2021-1

[5]
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics.

Nat Rev Gastroenterol Hepatol. 2021-9

[6]
Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis.

J Ren Nutr. 2018-10-23

[7]
Probiotics, Prebiotics, and Synbiotics for the Treatment and Prevention of Adult Dermatological Diseases.

Am J Clin Dermatol. 2017-12

[8]
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health.

Nutrients. 2017-9-15

[9]
The Role of Probiotics, Prebiotics and Synbiotics in Combating Multidrug-Resistant Organisms.

Clin Ther. 2020-9

[10]
Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.

Nat Rev Gastroenterol Hepatol. 2014-6-10

引用本文的文献

[1]
Ultra-Processed Foods, Gut Microbiota, and Inflammatory Bowel Disease: A Critical Review of Emerging Evidence.

Nutrients. 2025-8-19

[2]
BCL-2 Multi-Strain Probiotics for Immunomodulation In Vitro and In Vivo Alleviation of Atopic Dermatitis.

Microorganisms. 2025-8-21

[3]
The emerging role of the gut microbiome in depression: implications for precision medicine.

Mol Psychiatry. 2025-8-27

[4]
Respiratory diseases and the gut microbiota: an updated review.

Front Cell Infect Microbiol. 2025-8-11

[5]
A Review of Modulation of Gut Microbiota to Mitigate Gestational Diabetes: Implications for Maternal and Child Health.

Med Sci Monit. 2025-8-22

[6]
Effects of Probiotics and Synbiotics Supplementation on Blood Pressure in Adults with Prediabetes and Type 2 Diabetes Mellitus: A Grade-Assessed Systematic Review and Dose-Response Meta-Analysis.

Probiotics Antimicrob Proteins. 2025-8-15

[7]
The role of probiotics, prebiotics, and synbiotics in the treatment of inflammatory bowel diseases: an overview of recent clinical trials.

Front Syst Biol. 2025-4-16

[8]
Synbiotics: An Emerging Frontier in Infectious Diseases Control.

Probiotics Antimicrob Proteins. 2025-8-13

[9]
Effects of Probiotic and Synbiotic Supplementation on Glycemic Indices in Adult Individuals with Prediabetes and Type 2 Diabetes Mellitus: A Grade-Assessed Systematic Review and Dose-Response Meta-analysis of RCTs.

Probiotics Antimicrob Proteins. 2025-8-9

[10]
Microbiota-Host Interactions: Exploring Their Dynamics and Contributions to Human Diseases.

Microbiologyopen. 2025-8

本文引用的文献

[1]
Preventing Respiratory Tract Infections by Synbiotic Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Adv Nutr. 2020-7-1

[2]
Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents.

Cell. 2020-1-23

[3]
Postbiotics: facts and open questions. A position paper on the need for a consensus definition.

Benef Microbes. 2019-8-7

[4]
Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.

Dig Dis Sci. 2019-6-15

[5]
Emerging Health Concepts in the Probiotics Field: Streamlining the Definitions.

Front Microbiol. 2019-5-21

[6]
Dealing with the remaining controversies of probiotic safety.

Benef Microbes. 2019-5-27

[7]
Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.

Am J Clin Nutr. 2019-7-1

[8]
Improving End-User Trust in the Quality of Commercial Probiotic Products.

Front Microbiol. 2019-4-17

[9]
Frucooligosaccharides purification: Complexing simple sugars with phenylboronic acid.

Food Chem. 2019-1-31

[10]
Ameliorative effect of probiotics (Lactobacillus paracaseii and Protexin®) and prebiotics (propolis and bee pollen) on clindamycin and propionic acid-induced oxidative stress and altered gut microbiota in a rodent model of autism.

Cell Mol Biol (Noisy-le-grand). 2019-1-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索